House Bill Would Ban Reverse Payment Settlements
H.R. 1706, or the Protecting Consumer Access to Generic Drugs Act of 2009, introduced Wednesday, targets controversial so-called reverse payment settlements, which have already sparked lawsuits by consumers and the Federal Trade Commission.
A reverse payment settlement typically resolves a patent lawsuit by a brand name drugmaker against a generic rival over an abbreviated new drug application. Instead of risking...
To view the full article, register now.